The following was received from the
Illinois Emergency Management Agency (the Agency) via email:
[The licensee] contacted the Agency this afternoon to report a medical underdose of Y-90 that occurred today, April 19, 2021. Although information provided was preliminary, no untoward medical impact is expected to the patient.
[The] Radiation Safety Officer for the licensee contacted the Agency at 1515 CDT on April 19, 2021, to report a patient scheduled to receive Y-90 microsphere therapy (Theraspheres) for hepatocellular cancer received only 63 percent of the dose prescribed in the written directive. The Agency understands this to be one of three fractions delivered. Additional data is forthcoming.
Reportedly, the underdosing was due to a leakage of Y-90 microspheres in the connection between the Therasphere tubing and the microcatheter. The leakage resulted in area and personnel contamination which was promptly and successfully addressed by on-site radiation safety staff. No skin doses are reported or anticipated.
[The Agency] will dispatch staff to the site tomorrow for a reactionary inspection.
A Medical Event may indicate potential problems in a medical facility's use of radioactive materials. It does not necessarily result in harm to the patient.